Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3. Run chart for use of standardized instrument to assess level of control. Figure 3. Run chart for use of standardized instrument to assess level.

Published bySuhendra Tanudjaja Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 3. Run chart for use of standardized instrument to assess level of control. Figure 3. Run chart for use of standardized instrument to assess level."— Presentation transcript:

1 Figure 3. Run chart for use of standardized instrument to assess level of control.
Figure 3. Run chart for use of standardized instrument to assess level of control. Stars notate any statistically significant improvements compared to baseline. Julia Lee et al. BMJ Qual Improv Report 2016;5:u w6381 © 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to

Download ppt "Figure 3. Run chart for use of standardized instrument to assess level of control. Figure 3. Run chart for use of standardized instrument to assess level."

Similar presentations

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.
Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.

Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.
Summary of project team improvement efforts

Summary of project team improvement efforts
Effect of interventions on % appointments not attended

Effect of interventions on % appointments not attended
Run chart showing outcomes of interventions expressed as percentage of cases with active implantable cardioverter defibrillator (ICD) in situ postmortem. PDSA, Plan-Do-Study-Act.

Run chart showing outcomes of interventions expressed as percentage of cases with active implantable cardioverter defibrillator (ICD) in situ postmortem. PDSA, Plan-Do-Study-Act.
Run chart for measure 2 (adjusted timely morning discharge which is the percentage of patients who left by noon out of those eligible for morning discharge.

Run chart for measure 2 (adjusted timely morning discharge which is the percentage of patients who left by noon out of those eligible for morning discharge.
The poster displayed across the wards and on our Trust intranet

The poster displayed across the wards and on our Trust intranet
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.
Cumulative colorectal cancer mortality and all-cause mortality in persons in Vejle and Copenhagen counties invited to screening and in persons in the rest.

Cumulative colorectal cancer mortality and all-cause mortality in persons in Vejle and Copenhagen counties invited to screening and in persons in the rest.
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.
Photograph to show surface anatomy identified by Braunstein et al.

Photograph to show surface anatomy identified by Braunstein et al.
This a Pareto chart showing the data obtained from auditing the steps in the discharge process. This a Pareto chart showing the data obtained from auditing.

This a Pareto chart showing the data obtained from auditing the steps in the discharge process. This a Pareto chart showing the data obtained from auditing.
Mortality from CHD and stroke in women and men, by country and year.

Mortality from CHD and stroke in women and men, by country and year.
SPIRIT diagram. SPIRIT diagram. The figure details the timing of enrollment activities, intervention allocation, and assessments of outcomes over the course.

SPIRIT diagram. SPIRIT diagram. The figure details the timing of enrollment activities, intervention allocation, and assessments of outcomes over the course.
Flow chart for the DCL trial.

Flow chart for the DCL trial.
Fishbone diagram of the cause-and-effect analysis

Fishbone diagram of the cause-and-effect analysis
Burden of sepsis estimated from administrative data using ICD-10AM code preimplementation and postimplementation of sepsis pathway. ICD-10, International 

Burden of sepsis estimated from administrative data using ICD-10AM code preimplementation and postimplementation of sepsis pathway. ICD-10, International 
Deaths from non-communicable diseases among women in 2012, by cause, World Bank income category, and WHO region. Deaths from non-communicable diseases.

Deaths from non-communicable diseases among women in 2012, by cause, World Bank income category, and WHO region. Deaths from non-communicable diseases.
Figure 4. Run chart for medication dosage as per national asthma care guideline. Figure 4. Run chart for medication dosage as per national asthma care.

Figure 4. Run chart for medication dosage as per national asthma care guideline. Figure 4. Run chart for medication dosage as per national asthma care.
Schematic representation of referral process (1a) and suggested areas to improve the referral process of the Emergency clinic (1b). Schematic representation.

Schematic representation of referral process (1a) and suggested areas to improve the referral process of the Emergency clinic (1b). Schematic representation.

Similar presentations

Ads by Google